文献速递肝病

肝病与远程医疗:新冠疫情能否推动行动?

Telemedicine in Liver Disease and Beyond: Can the COVID-19 Crisis Lead to Action?
PubMed 文献 · Hepatology · 2020-01-01

本文论述肝硬化专科诊疗可提高指南依从性并改善结局,但仅约半数肝硬化相关并发症住院接受专科诊疗,现有肝病人力难以满足全国需求;远程医疗技术廉价易用但受州际执照与报销限制,新冠疫情短期加速其应用,作者以远程肝病项目案例探讨危机能否推动常规医疗中更广泛采用。

要点

  • 肝硬化专科诊疗与更高指南依从性和更好临床结局相关。
  • 仅约半数肝硬化相关并发症急性住院接受住院专科诊疗。
  • 远程医疗受州际执照限制和报销障碍制约,疫情短期加速其增长。

核心结论

  • 证据支持肝硬化患者获得消化内科或肝病专科诊疗与更高指南依从性和临床结局改善相关。
  • 远程医疗有望增加广泛专科诊疗可及性,但当前受州际执照限制和报销障碍制约规模。
  • 新冠疫情作为公共卫生和社交距离措施短期加速了远程医疗服务的增长。

研究设计与样本

  • 本文为论述性文章,以作者远程肝病项目的病例系列作为务实示例。

主要发现

  • 目前仅约半数肝硬化相关并发症的急性住院导致住院专科诊疗。
  • 当前肝病人力无法满足全国肝病患者需求,尤其在人口密度较低地区和未附属学术中心的社区实践。
  • 远程医疗技术廉价且易于使用,但当前受州际执照限制和报销障碍制约规模。

临床怎么用

  • 可将远程医疗作为增加肝病专科诊疗可及性的手段,但需关注州际执照与报销障碍。
  • 疫情期远程医疗加速增长的经验可用于讨论非危机情况下常规医疗的更广泛采用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Evidence strongly supports that access to specialty gastroenterology or hepatology care in cirrhosis is associated with higher adherence to guideline-recommended care and improves clinical outcomes. Presently, only about one half of acute care hospitalizations for cirrhosis-related complications result in inpatient specialty care, and the current hepatology workforce cannot meet the demand of patients with liver disease nationwide, particularly in less densely populated areas and in community-based practices not affiliated with academic centers. Telemedicine, defined as the delivery of health care services at a distance using electronic means for diagnosis and treatment, holds tremendous promise to increase access to broadly specialty care. The technology is cheap and easy to use, although it is presently limited in scale by interstate licensing restrictions and reimbursement barriers. The outbreak of severe acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 has, in the short term, accelerated the growth of telemedicine delivery as a public health and social distancing measure. Herein, we examine whether this public health crisis can accelerate the national conversation about broader adoption of telemedicine for routine medical care in non-crisis situations, using a case series from our telehepatology program as a pragmatic example.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Serper M, Cubell AW, Deleener ME, et al. Telemedicine in Liver Disease and Beyond: Can the COVID-19 Crisis Lead to Action? Hepatology. 2020. PMID: 32275784. doi:10.1002/hep.31276

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。